Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Firms Eye Alliances, Global Markets To Become ‘Next Takeda’

Executive Summary

Alliances and expansion into international markets, helped by M&A, are seen by many growing and research-focused Chinese pharma companies as essential to their business development aspirations, although a recent industry forum in Changzhou also heard that such firms should keep a firm footing at home to become an attractive partner.

Advertisement

Related Content

2016 Review: Pricing, R&D Issues Dominate China Commercial Arena
Curb Your Enthusiasm: Chinese Pharmas Going Global Hit Speed Bumps
Hengrui Pursues Innovation Through New $100m US Spinoff

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097247

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel